Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $26.0000 (13.04%) ($23.0000 - $26.0000) on Wed. Dec. 4, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1029.71% (three month average) | RSI | 98 | Latest Price | $26.0000(13.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) IWM(7%) JNK(7%) OIH(7%) PEJ(7%) | Factors Impacting CAPR price | CAPR will decline at least -514.855% in a week (0% probabilities). TLT(-3%) SHY(-1%) GLD(-1%) TIP(1%) LQD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -514.855% (StdDev 1029.71%) | Hourly BBV | 0 () | Intraday Trend | 4% | | | |
|
Resistance Level | $27.91 | 5 Day Moving Average | $25.6(1.56%) | 10 Day Moving Average | $25.23(3.05%) | 20 Day Moving Average | $27.91(-6.84%) | To recent high | -44.1% | To recent low | 15.6% | Market Cap | $512m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |